Advertisement

Latest Articles in pharma news

Centre Revokes Licenses Of 18 Pharma Companies For Manufacturing Spurious Drugs: Report

The government of India has canceled the licenses of 18 pharma companies for manufacturing of spurious medicines following an inspection by the Drugs Controller General of India (DCGI) on 76 companies across 20 States

Read More

Zydus Gets Final Approvals From USFDA To Market Generic Drugs

Zydus Lifesciences on Tuesday informed that it has received final approval for two drugs from the United States Food and Drug Administration (USFDA) including Doxepin Hydrochloride Capsules and Levothyroxine Sodium for Injection

Read More

Hurting Generic Industry Compelling Pharma To Spend More On R&D

Industry experts contend that largely the research budgets of the top firms have remained flattish in the last two to three years on account of Covid, but the scenario might be changing for some select firms like Sun Pharmaceuticals, Dr Reddy’s Labs, Zydus Lifesciences, Cipla and Biocon Biologics a

Read More

India Must Focus On Biopharmaceuticals To Feed The Growth Engine: Kiran Mazumdar Shaw

In an exclusive conversation with BW Healthcare World, Kiran Mazumdar Shaw, Executive Chairperson, Biocon & Biocon Biologics delineates on how Indian pharma can move up the value chain, while also speaking on Biocon's R&D investments and future plans

Read More

India Below-par As The World’s Pharmacy: A Call To Action

One of the main challenges facing India's pharmaceutical industry is the issue of quality control. In 2018, the US Food and Drug Administration (FDA) raised concerns over the quality of drugs produced by some Indian pharmaceutical companies

Read More

Alembic Pharma Gets USFDA Approval For Brexpiprazole Tablets

Brexpiprazole Tablets are indicated as adjunctive therapy to antidepressants for the treatment of major depressive disorder and for the treatment of schizophrenia

Read More

Indian Co Global Pharma Healthcare Recalls Eye Drops Over 55 Adverse Events In US

Chennai-based drug firm Global Pharma Healthcare is voluntarily recalling all lots within expiry of their Artificial Tears Lubricant Eye Drops, distributed by /EzriCare, LLC- and Delsam Pharma, to the consumer level, due to possible contamination, the USFDA on Thursday said in a statement

Read More

Sun Pharma Reports Surge In Net Profits By 5% YoY In Q3FY23

Sun Pharmaceutical, the Indian pharma company headquartered in Mumbai on Tuesday announced its consolidated financial results for the third quarter that ended 31st December 2022, the company registered a 13.1 per cent rise in its revenues from operations year on year

Read More

Dr Reddy’s Labs Completes Clinical Studies For Its Rituximab Biosimilar For Filing In US, Europe

Dr Reddy’s Laboratories, a global pharmaceutical company announced that it has successfully completed the full set of clinical studies of its proposed rituximab biosimilar candidate, DRL_RI, for filing in highly regulated markets such as the United States, Europe and other regions, the pharma major

Read More

AbbVie & Eli Lilly Step Back From UK Drug Pricing Agreement

Companies are increasingly arguing that it is no longer possible to justify the UK's "voluntary scheme" to global boardrooms and investors as repayment rates in 2023 have surged to 26.5 per cent of revenue, the Association of the British Pharmaceutical Industry (ABPI) said in a statement

Read More